Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

[img]
Preview
s13023-021-01758-9.pdf - Published Version (1MB) | Preview
Available under license: Creative Commons Attribution

Kourakis, S, Timpani, Cara ORCID: 0000-0003-4567-4319, Campelj, DG, Hafner, P, Gueven, Nuri, Fischer, Dirk and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2021) Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? Orphanet Journal of Rare Diseases, 16 (1). ISSN 1750-1172 (In Press)

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/42092
DOI https://doi.org/10.1186/s13023-021-01758-9
Official URL https://ojrd.biomedcentral.com/articles/10.1186/s1...
Subjects Historical > FOR Classification > 0601 Biochemistry and Cell Biology
Historical > FOR Classification > 1116 Medical Physiology
Current > Division/Research > Institute for Health and Sport
Keywords pharmacological corticosteroid therapy, Duchenne Muscular Dystrophy, mutations, dystrophin gene, truncated dystrophin protein
Citations in Scopus 1 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login